CoreLogic

CoreLogic is a Washington, DC-based biotechnology company that provides a leading machine learning platform designed to transform the life sciences industry. Founded in 2025, the company specializes in automating complex enterprise workflows using advanced AI models, enabling pharmaceutical and biotech firms to accelerate drug discovery and development processes. In October 2025, CoreLogic closed a significant $300 million Series D funding round led by NEA, valuing the company at $2 billion. The platform integrates deep learning and predictive analytics to provide data-driven insights that optimize research and operational efficiency. CoreLogic's technology is positioned as a critical infrastructure for the next generation of AI-enabled life sciences companies.